About this trial
The goal of this pilot study is to understand and improve the shared decision-making process between people with advanced breast cancer and their providers regarding their care and treatment. As part of this study, the researchers will evaluate a decision support tool called COAST that was designed to support patients and providers in having meaningful conversations. The main questions it aims to answer are:
1. Can the COAST tool improve the quality of communication between patients and their oncology providers? 2. Is the COAST tool acceptable, appropriate, and easy to use at NYP-Weill Cornell Medicine, NYP-Brooklyn Methodist Hospital and NYP-Queens?
Participants will be asked to fill out two surveys: one before they use the COAST tool and another about 2 - 4 weeks later. Some patients will also be invited for an interview.
Eligibility criteria
Qualifiers
Male or female 18 years and older
Diagnosis of Stage IV breast cancer
English, Spanish or Mandarin speaking
Disqualifiers
Early breast cancer
Individuals speaking languages other than English, Spanish, or Mandarin as their primary language
Trial design
Treatments tested in this trial
- Decision Support Tool
Treatment groups
Locations
3Sponsors and collaborators
Weill Medical College of Cornell University
Lead sponsor
Gilead Sciences
Collaborator